{"result": "(\"entity\"<|>METOCLOPRAMIDA<|>ORGANIZATION<|>Metoclopramida is a medication that acts as a procinético, promoting gastric emptying and stimulating intestinal motility.)\n##\n(\"entity\"<|>CISAPRIDA<|>ORGANIZATION<|>Cisaprida is a medication that acts as a procinético, promoting gastric emptying and stimulating intestinal motility.)\n##\n(\"entity\"<|>DOMPERIDONA<|>ORGANIZATION<|>Domperidona is a medication that acts as a procinético, promoting gastric emptying and stimulating intestinal motility.)\n##\n(\"entity\"<|>ANTIBIÓTICOS<|>ORGANIZATION<|>Antibióticos are medications that can cause changes in intestinal flora.)\n##\n(\"entity\"<|>ALUMINIO<|>ORGANIZATION<|>Aluminio is a component found in some antiacids that can inhibit gastric motility.)\n##\n(\"relationship\"<|>METOCLOPRAMIDA<|>NUTRICIÓN ENTERAL<|>Metoclopramida is used to promote gastric emptying in patients receiving enteral nutrition<|>5)\n##\n(\"relationship\"<|>CISAPRIDA<|>NUTRICIÓN ENTERAL<|>Cisaprida is used to promote gastric emptying in patients receiving enteral nutrition<|>5)\n##\n(\"relationship\"<|>DOMPERIDONA<|>NUTRICIÓN ENTERAL<|>Domperidona is used to promote gastric emptying in patients receiving enteral nutrition<|>5)\n##\n(\"relationship\"<|>ANTIBIÓTICOS<|>NUTRICIÓN ENTERAL<|>Antibióticos can alter the intestinal flora in patients receiving enteral nutrition<|>4)\n##\n(\"relationship\"<|>ALUMINIO<|>NUTRICIÓN ENTERAL<|>Aluminio in antiacids can inhibit gastric motility, affecting patients on enteral nutrition<|>4)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: inhiben la motilidad gástrica: antihistamínicos, antidepresivos tricíclicos, fenotiacinas, antiparkinsonianos\n   - Antiácidos que contengan aluminio\n   - Opiáceos\n\n2. Agentes procinéticos: favorecen el vaciamiento gástrico y estimulan la motilidad intestinal:\n   - Metoclopramida, cisaprida, domperidona, etc.\n\n3. Fármacos que originan cambios en la flora intestinal: antibióticos.\n\n4. Otros (inhiben las secreciones pancreáticas, modifican el pH gástrico, etc.).\n\nModificado de Montoro².\n\ne) Interacción farmacocinética: se habla de interacciones farmacocinéticas cuando, a consecuencia de la administración conjunta de fármacos y nutrición enteral, se produce alguna alteración en los procesos de absorción, distribución, metabolismo o excreción del fármaco o del preparado nutricional¹². Los niveles plasmáticos de fenitoína, por ejemplo, se reducen en 70-80% cuando se administra con nutrición enteral, aunque se elevan cuando la administración de la nutrición se interrumpe 2 horas antes y hasta 2 horas después de la administración del fármaco¹⁹.\n\nf) Interacción farmacodinámica: tiene lugar cuando se producen alteraciones en la acción farmacológica del medicamento o bien en las propiedades nutritivas del preparado, sin una modificación en la farmacocinética del primero o en la biodisponibilidad del segundo. En este tipo de interacciones influyen principalmente dos mecanismos: el antagonismo farmacológico o la alteración de sistemas de transporte celular. Uno de los ejemplos de este tipo de interacción es el antagonismo que el contenido en vitamina K de la nutrición enteral puede originar sobre la acción terapéutica de los anticoagulantes orales. En un principio se creía que el contenido de las nutriciones en vitamina K era el responsable de dicho efecto y se recomendaba que se utilizaran dietas enterales con un contenido en vitamina K inferior a 75-80 mg/1.000 kcal y que se vigilase el tiempo de protrombina¹². Sin embargo, se ha visto que el antagonismo sigue existiendo en preparados sin apenas contenido en vitamina K, por lo que el mecanismo postulado actualmente es una altera-\n\nción en la absorción de warfarina debido a la unión con las proteínas de la nutrición².\n\n7. Prevención de la interacción medicamentos-nutrición enteral: recomendaciones para la administración de medicamentos\n\nEn aquellos pacientes que reciben nutrición enteral, deberían extremarse las precauciones para minimizar en lo posible la aparición de interacciones (tabla 6). Cuando sea posible que el paciente reciba los medicamentos por vía oral (por ejemplo, cuando la indicación de la nutrición enteral es la anorexia o la malabsorción), esta vía será preferente, puesto que permite conservar la forma farmacéutica original. En los casos en que es necesario administrar los medicamentos a través de sonda u ostomía, es preferible el empleo de formas farmacéuticas líquidas, preferiblemente diluidas antes de su administración, especialmente si presentan elevada osmolalidad. Sin embargo, con frecuencia no se dispone de estas formulaciones y se debe recurrir a triturar formas farmacéuticas sólidas. Debemos recordar que algunas formas farmacéuticas sólidas no deben triturarse:\n\n- Formas farmacéuticas de cubierta entérica, diseñadas para que el principio activo pueda pasar intacto a través del estómago y liberarse en el intestino, bien para evitar la degradación del principio activo en el medio ácido del estómago, prevenir la irritación gástrica o bien retrasar el inicio de la acción del fármaco.\n- Formas farmacéuticas de liberación retardada, ya que se destruye también el mecanismo de liberación retardada, con lo cual puede aparecer toxicidad farmacológica en el pico de absorción.\n- Formas farmacéuticas de absorción sublingual, que contienen habitualmente una dosis menor que cuando se administran por vía digestiva, ya que se absorben directamente a la circulación general y no al sistema porta. Su administración vía tracto gastrointestinal puede disminuir la eficacia.\n- Comprimidos efervescentes.\n- Cápsulas que contienen gránulos con recubrimiento entérico, que preservan la integridad de la medicación hasta que llega al pH alcalino del duodeno, como el omeprazol. No se deben triturar y disolver en agua, ya que se inactivaría en el estómago. Por otro lado, los gránulos pueden obstruir la sonda. Las cápsulas pueden abrirse, mezclar los gránulos sin triturar con 20 ml de zumo ácido de frutas y administrar por la sonda²⁰.\n-\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>MONTORO<|>PERSON<|>Montoro is referenced in the context of pharmacological interactions and recommendations for medication administration in enteral nutrition.)\n##\n(\"entity\"<|>FENITOÍNA<|>ORGANIZATION<|>Fenitoína is a medication whose plasma levels are affected by enteral nutrition, showing a significant reduction when administered together with it.)\n##\n(\"entity\"<|>WARFARINA<|>ORGANIZATION<|>Warfarina is an anticoagulant whose absorption is altered due to interactions with enteral nutrition.)\n##\n(\"entity\"<|>NUTRICIÓN ENTERAL<|>ORGANIZATION<|>Nutrición enteral refers to the method of delivering nutrients directly into the gastrointestinal tract, which can interact with medications.)\n##\n(\"entity\"<|>ANTICOAGULANTES ORALES<|>ORGANIZATION<|>Anticoagulantes orales are oral anticoagulants that can be affected by the vitamin K content in enteral nutrition.)\n##\n(\"entity\"<|>AGENTES PROCINÉTICOS<|>ORGANIZATION<|>Agentes procinéticos are medications that promote gastric emptying and stimulate intestinal motility.)\n##\n(\"entity\"<|>ANTIHISTAMÍNICOS<|>ORGANIZATION<|>Antihistamínicos are medications that inhibit gastric motility.)\n##\n(\"entity\"<|>OPIÁCEOS<|>ORGANIZATION<|>Opiáceos are medications that inhibit gastric motility.)\n##\n(\"entity\"<|>ANTIDEPRESIVOS TRICÍCLICOS<|>ORGANIZATION<|>Antidepresivos tricíclicos are medications that inhibit gastric motility.)\n##\n(\"entity\"<|>FENOTIACINAS<|>ORGANIZATION<|>Fenotiacinas are medications that inhibit gastric motility.)\n##\n(\"entity\"<|>ANTIPARKINSONIANOS<|>ORGANIZATION<|>Antiparkinsonianos are medications that inhibit gastric motility.)\n##\n(\"relationship\"<|>MONTORO<|>NUTRICIÓN ENTERAL<|>Montoro discusses the interactions between medications and enteral nutrition<|>7)\n##\n(\"relationship\"<|>FENITOÍNA<|>NUTRICIÓN ENTERAL<|>Fenitoína's plasma levels are significantly reduced when administered with enteral nutrition<|>8)\n##\n(\"relationship\"<|>WARFARINA<|>NUTRICIÓN ENTERAL<|>Warfarina's absorption is altered due to interactions with enteral nutrition<|>8)\n##\n(\"relationship\"<|>ANTICOAGULANTES ORALES<|>NUTRICIÓN ENTERAL<|>Anticoagulantes orales are affected by the vitamin K content in enteral nutrition<|>6)\n##\n(\"relationship\"<|>AGENTES PROCINÉTICOS<|>NUTRICIÓN ENTERAL<|>Agentes procinéticos are used to promote gastric emptying in patients receiving enteral nutrition<|>5)\n##\n(\"relationship\"<|>ANTIHISTAMÍNICOS<|>NUTRICIÓN ENTERAL<|>Antihistamínicos inhibit gastric motility, which can affect patients on enteral nutrition<|>5)\n##\n(\"relationship\"<|>OPIÁCEOS<|>NUTRICIÓN ENTERAL<|>Opiáceos inhibit gastric motility, which can affect patients on enteral nutrition<|>5)\n##\n(\"relationship\"<|>ANTIDEPRESIVOS TRICÍCLICOS<|>NUTRICIÓN ENTERAL<|>Antidepresivos tricíclicos inhibit gastric motility, which can affect patients on enteral nutrition<|>5)\n##\n(\"relationship\"<|>FENOTIACINAS<|>NUTRICIÓN ENTERAL<|>Fenotiacinas inhibit gastric motility, which can affect patients on enteral nutrition<|>5)\n##\n(\"relationship\"<|>ANTIPARKINSONIANOS<|>NUTRICIÓN ENTERAL<|>Antiparkinsonianos inhibit gastric motility, which can affect patients on enteral nutrition<|>5)\n<|COMPLETE|>"}]}